139 related articles for article (PubMed ID: 35341920)
1. Synthesis of harmine-nitric oxide donor derivatives as potential antitumor agents.
Li Z; Apizi Y; Zhang C; Wang Z; He H; Li X; Zhu Y; Yang J; Xiao L; Wang M
Bioorg Med Chem Lett; 2022 Jun; 65():128698. PubMed ID: 35341920
[TBL] [Abstract][Full Text] [Related]
2. Novel nitric oxide-releasing derivatives of pyranocarbazole as antitumor agents: Design, synthesis, biological evaluation, and nitric oxide release studies.
Zang Y; Huang L; Chen X; Li C; Ma J; Chen X; Zhang D; Lai F
Eur J Med Chem; 2022 Dec; 244():114832. PubMed ID: 36270090
[TBL] [Abstract][Full Text] [Related]
3. Antitumor and neurotoxic effects of novel harmine derivatives and structure-activity relationship analysis.
Chen Q; Chao R; Chen H; Hou X; Yan H; Zhou S; Peng W; Xu A
Int J Cancer; 2005 May; 114(5):675-82. PubMed ID: 15609303
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and preliminary mechanisms of 6-amino substituted harmine derivatives as potential antitumor agents.
Hu D; Han G; Ren H; Li X; Li X; Yue L; Xu J; Feng J; Guo L
Fitoterapia; 2022 Nov; 163():105329. PubMed ID: 36209955
[TBL] [Abstract][Full Text] [Related]
5. Novel anticancer oridonin derivatives possessing a diazen-1-ium-1,2-diolate nitric oxide donor moiety: Design, synthesis, biological evaluation and nitric oxide release studies.
Xu S; Wang G; Lin Y; Zhang Y; Pei L; Yao H; Hu M; Qiu Y; Huang Z; Zhang Y; Xu J
Bioorg Med Chem Lett; 2016 Jun; 26(12):2795-2800. PubMed ID: 27158140
[TBL] [Abstract][Full Text] [Related]
6. Novel NO-releasing plumbagin derivatives: Design, synthesis and evaluation of antiproliferative activity.
Bao N; Ou J; Xu M; Guan F; Shi W; Sun J; Chen L
Eur J Med Chem; 2017 Sep; 137():88-95. PubMed ID: 28558333
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of harmine derivatives as topoisomerase I inhibitors for cancer treatment.
Guo YL; Yu JW; Cao Y; Cheng KX; Dong-Zhi SN; Zhang YF; Ren QJ; Yin Y; Li CL
Eur J Med Chem; 2024 Feb; 265():116061. PubMed ID: 38154256
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and biological activity evaluation of novel scopoletin-NO donor derivatives against MCF-7 human breast cancer in vitro and in vivo.
Yu N; Li N; Wang K; Deng Q; Lei Z; Sun J; Chen L
Eur J Med Chem; 2021 Nov; 224():113701. PubMed ID: 34315044
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel ferrocene-pyrazole derivatives containing nitric oxide donors as COX-2 inhibitors for cancer therapy.
Ren SZ; Wang ZC; Zhu D; Zhu XH; Shen FQ; Wu SY; Chen JJ; Xu C; Zhu HL
Eur J Med Chem; 2018 Sep; 157():909-924. PubMed ID: 30149323
[TBL] [Abstract][Full Text] [Related]
10. Harmine-inspired design and synthesis of benzo[d]imidazo[2,1-b]thiazole derivatives bearing 1,3,4-oxadiazole moiety as potential tumor suppressors.
Zhao T; Yang Y; Yang J; Cui Y; Cao Z; Zuo D; Zhai X
Bioorg Med Chem; 2021 Sep; 46():116367. PubMed ID: 34425477
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis and anti-tumor evaluation of novel steroidal glycoconjugate with furoxan derivatives.
Li H; Wang K; Wan Q; Chen Y
Steroids; 2019 Jan; 141():81-95. PubMed ID: 30521816
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of harmine derivatives as potential antitumor agents.
Cao R; Fan W; Guo L; Ma Q; Zhang G; Li J; Chen X; Ren Z; Qiu L
Eur J Med Chem; 2013 Feb; 60():135-43. PubMed ID: 23291116
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and cytotoxic evaluation of nitric oxide-releasing derivatives of isosteviol.
Liu Y; Wang T; Ling Y; Bao N; Shi W; Chen L; Sun J
Chem Biol Drug Des; 2017 Sep; 90(3):473-477. PubMed ID: 28122177
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of novel hybrids of phenylsulfonyl furoxan and phenstatin derivatives as potent anti-tumor agents.
Huang X; Wang YS; Ma D; Wang YY; Bian SD; Zhang B; Qiao Y; He ZR; Lv M; Cai GL; Wang ZX; Liu XS; Shi JB; Liu MM
Eur J Med Chem; 2022 Feb; 230():114112. PubMed ID: 35065411
[TBL] [Abstract][Full Text] [Related]
15. Novel nitric oxide-releasing derivatives of farnesylthiosalicylic acid: synthesis and evaluation of antihepatocellular carcinoma activity.
Ling Y; Ye X; Zhang Z; Zhang Y; Lai Y; Ji H; Peng S; Tian J
J Med Chem; 2011 May; 54(9):3251-9. PubMed ID: 21504204
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide-donating derivatives of hederacolchiside A
Fang Y; Wang R; He M; Huang H; Wang Q; Yang Z; Li Y; Yang S; Jin Y
Bioorg Med Chem Lett; 2017 Jan; 27(1):98-101. PubMed ID: 27866816
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, antiproliferative activity, and molecular modeling of novel 4-methylcoumarin derivatives and/or nitric oxide donor hybrids.
Mohamed MS; Elsherief HAM; Hafez HM; Alsaidan OA; Alzarea SI; AboulMagd AM
Mol Divers; 2023 Oct; 27(5):2133-2146. PubMed ID: 36272042
[TBL] [Abstract][Full Text] [Related]
18. A novel harmine derivative, N-(4-(hydroxycarbamoyl)benzyl)-1-(4- methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxamide (HBC), as histone deacetylase inhibitor: in vitro antiproliferation, apoptosis induction, cell cycle arrest, and antimetastatic effects.
Miao JF; Peng YF; Chen S; Gao WJ; Yang QX; Zhu P; Guo J; Tao J; Luo L; Zhang Y; Ling Y
Eur J Pharmacol; 2018 Apr; 824():78-88. PubMed ID: 29428472
[TBL] [Abstract][Full Text] [Related]
19. New 1,2,4-triazole/pyrazole hybrids linked to oxime moiety as nitric oxide donor celecoxib analogs: Synthesis, cyclooxygenase inhibition anti-inflammatory, ulcerogenicity, anti-proliferative activities, apoptosis, molecular modeling and nitric oxide release studies.
Fadaly WAA; Elshaier YAMM; Hassanein EHM; Abdellatif KRA
Bioorg Chem; 2020 May; 98():103752. PubMed ID: 32197148
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological evaluation of nitric oxide-releasing 5-cyano-6-phenyl-2, 4-disubstituted pyrimidine derivatives.
Chi L; Wang H; Yu F; Gao C; Dai H; Si X; Dong Y; Liu H; Zhang Q
Bioorg Med Chem Lett; 2023 Aug; 92():129389. PubMed ID: 37379957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
